Daniel Carter

University of Technology, Sydney

Australia

Research Interests

Explore related searches

Professors in Australia Professors in Cancer Biology Cancer Biology professors in Australia

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (7)

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (11)

Frank Speleman

Ghent University

BELGIUM

View details

Mark Zimmerman

Dana-Farber Cancer Institute

UNITED STATES

View details

Belamy Cheung

UNSW Sydney

AUSTRALIA

View details

Pooja Venkat

Murdoch Childrens Research Institute

AUSTRALIA

View details

Shruthi Subramanian

Oregon Health & Science University

UNITED STATES

View details

Natalia Issaeva

Assistant Profeessor

University of North Carolina at Chapel Hill

UNITED STATES

View details

Yizhou Huang

AUSTRALIA

View details

Owen Tan

Macquarie University

AUSTRALIA

View details

Alvin Kamili

Children's Cancer Institute Australia

AUSTRALIA

View details

Jingwei Chen

Children's Cancer Institute Australia

AUSTRALIA

View details

Kaat Durinck

professor (tenure track)

Ghent University

BELGIUM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Daniel Carter

Research Interests

Explore related searches

Contact this professor

Articles (7)

Disruption of a GATA2-TAL1-ERG regulatory circuit promotes erythroid transition in healthy and leukemic stem cells

Dual targeting of chromatin stability by the curaxin CBL0137 and histone deacetylase inhibitor panobinostat shows significant preclinical efficacy in neuroblastoma.

A novel combination therapy targeting ubiquitin-specific protease 5 in MYCN-driven neuroblastoma

MEIS2 Is an Adrenergic Core Regulatory Transcription Factor Involved in Early Initiation of TH-MYCN-Driven Neuroblastoma Formation

An ALYREF-MYCN coactivator complex drives neuroblastoma tumorigenesis through effects on USP3 and MYCN stability

Oncogenic cooperation between TCF7-SPI1 and NRAS(G12D) requires β-catenin activity to drive T-cell acute lymphoblastic leukemia

Combination therapy with the CDK7 inhibitor and the tyrosine kinase inhibitor exerts synergistic anticancer effects against MYCN-amplified neuroblastoma.

Collaborators (11)

Frank Speleman

Mark Zimmerman

Belamy Cheung

Pooja Venkat

Shruthi Subramanian

Natalia Issaeva

Yizhou Huang

Owen Tan

Alvin Kamili

Jingwei Chen

Kaat Durinck

Make your next move.